An Open Clinical trial to evaluate the effectiveness of Nilavagai chooranam (Internal)and Thaengai thylam (External)in the management of Karappan (Atopic Dermatitis)in Childre
Phase 3
- Conditions
- Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissueHealth Condition 2: L00-L08- Infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/05/053291
- Lead Sponsor
- Dr S ESWARI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of both sexes in the age group of 3 to 12 years with
Major criteria (3 of 4 must be met):
• Pruritis
• Chronic or chronically relapsing dermatitis
• Typical morphology and distribution
• Personal or family history of atopic disease (asthma, allergic rhinitis, AD)
Minor criteria:
• Xerosis
• Ichthyosis/hyperlinear palms/keratosis pilaris
• Elevated serum IgE
• Early age of onset
• Pruritis when sweating
• Food hypersensitivity
• White dermographism or delayed blanch to cholinergic agent
Exclusion Criteria
1.K/C/O Scabies
2.H/O Contact dermatitis
3.H/O Seborrheic Dermatitis
4.H/O Psoriasis
5.K/C/O Secondary Bacterial Infections
6.K/C/O Furunculosis
7.K/C/O Neurodermatitis
8.Any other serious illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method